
Blogs
Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.
EMPLOYEE SPOTLIGHT: Elise Gafford
This month, CancerLinQ is excited to feature one of our extremely talented software engineers, Elise Gafford. Elise currently serves as Lead Software…
The Updated SmartLinQ™ Application Offers Customizable Solutions from CancerLinQ® and Other Innovators
Melissa Miller, Senior Director Product Management and Strategy
In our continued commitment to help oncologists and care teams optimize how they treat patients, we want to accommodate more and more of the…
EMPLOYEE SPOTLIGHT: Jacob Koskimaki
Meet Jacob Koskimaki, CancerLinQ’s Director of Data Analytics and Commercial Operations. Jacob’s path to CancerLinQ brings a wealth of knowledge and…
Perspectives from Chicago: The 2022 ASCO Quality Care Symposium
Robert S. Miller, MD, FACP, FASCO, FAMIA
This past weekend I had a lovely 2 days in Chicago at #ASCOQLTY22, as it is known in the Twitterverse, with fellow ASCO staff and 600+ attendees.
Updated September 12, 2022: Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
Patients with cancer and COVID-19 constitute those with a cancer diagnosis who fit at least one of the
following three criteria:
following three criteria:
EMPLOYEE SPOTLIGHT: Alex Brombal
Alex Brombal is a Senior Software Engineer for CancerLinQ, and his primary focus is on the SmartLinQ web application and related products. He is…
Updated August 8, 2022: Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
Updated July 7, 2022: Demographics of Patients with Cancer and COVID-19 Disease
How CancerLinQ Patient Intelligence 360 Makes Real-World Oncology Data Ready for Use
Jose Ulises Mena, CancerLinQ Director of Data and Bioinformatics
When ASCO launched CancerLinQ nearly a decade ago, patient data was very difficult to access because it was siloed away in file cabinets and…
How Owkin and CancerLinQ aim to improve lung cancer treatment using federated learning
CancerLinQ and Owkin announced a new research collaboration to work together to use artificial intelligence to understand the treatment of non-small…